We are live on ! Find out more
Handelsbanken Fonder

Handelsbanken Fonder Portfolio holdings

AUM $35.1B
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
+20.94%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$16.4B
AUM Growth
+$2.8B
Cap. Flow
+$574M
Cap. Flow %
3.49%
Top 10 Hldgs %
21.48%
Holding
1,573
New
122
Increased
458
Reduced
207
Closed
28

Sector Composition

Rank Sector Weight
1 Technology 26.68%
2 Healthcare 16.65%
3 Consumer Discretionary 14.09%
4 Financials 11.64%
5 Industrials 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MS icon
151
Morgan Stanley
MS
$342B
$23.2M 0.14%
338,866
+60,857
+22% +$3.49M
CVCO icon
152
Cavco Industries
CVCO
$4.6B
$23.2M 0.14%
131,986
+10,000
+8% +$1.86M
ISRG icon
153
Intuitive Surgical
ISRG
$142B
$22.7M 0.14%
83,382
+1,500
+2% +$372K
SCHW
154
Charles Schwab
SCHW
$189B
$22.5M 0.14%
424,614
+147,016
+53% +$6.66M
GE icon
155
GE Aerospace
GE
$379B
$22.4M 0.14%
416,388
+7,459
+2% +$334K
PTCT icon
156
PTC Therapeutics
PTCT
$6.06B
$22.3M 0.14%
365,800
-11,000
-3% -$648K
GS icon
157
Goldman Sachs
GS
$302B
$21.7M 0.13%
82,331
+1,800
+2% +$401K
IAA
158
DELISTED
IAA, Inc. Common Stock
IAA
$21.7M 0.13%
333,725
-40,000
-11% -$2.39M
BKNG icon
159
Booking.com
BKNG
$159B
$21.7M 0.13%
243,100
+400
+0.2% +$30.9K
TEL icon
160
TE Connectivity
TEL
$62B
$21.4M 0.13%
176,555
-9,740
-5% -$1.07M
NBIS
161
Nebius Group N.V.
NBIS
$70.5B
$21.3M 0.13%
306,319
-1,200
-0.4% -$76.6K
CVS icon
162
CVS Health
CVS
$121B
$21.2M 0.13%
310,429
+3,266
+1% +$212K
DE icon
163
Deere & Co
DE
$167B
$21.2M 0.13%
78,803
+3,707
+5% +$921K
TGT icon
164
Target
TGT
$69.9B
$21M 0.13%
119,040
+1,263
+1% +$211K
ARNA
165
DELISTED
Arena Pharmaceuticals Inc
ARNA
$20.9M 0.13%
271,830
+37,900
+16% +$2.84M
ZION icon
166
Zions Bancorporation
ZION
$10.5B
$20.9M 0.13%
480,700
+131,000
+37% +$4.84M
GILD icon
167
Gilead Sciences
GILD
$168B
$20.8M 0.13%
357,126
+60,630
+20% +$3.66M
EBAY icon
168
eBay
EBAY
$45.5B
$20.5M 0.12%
408,045
-83,553
-17% -$4.27M
PFPT
169
DELISTED
Proofpoint, Inc.
PFPT
$20.5M 0.12%
150,130
-20,000
-12% -$2.19M
AKAM icon
170
Akamai
AKAM
$17.6B
$20.2M 0.12%
192,528
-10,600
-5% -$1.11M
GLUU
171
DELISTED
Glu Mobile Inc.
GLUU
$20.1M 0.12%
2,227,800
MU icon
172
Micron Technology
MU
$1.03T
$20M 0.12%
266,346
+579
+0.2% +$34.9K
BHVN
173
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$19.9M 0.12%
232,600
-36,900
-14% -$3.13M
MDLZ icon
174
Mondelez International
MDLZ
$79.4B
$19.8M 0.12%
338,612
+6,500
+2% +$372K
AXON
175
Axon Enterprise
AXON
$48.7B
$19.8M 0.12%
161,402
-10,000
-6% -$1.15M

Similar funds

Handelsbanken Fonder's Q4 2020 Portfolio in Review

As of Q4 2020, Handelsbanken Fonder held 1,573 positions worth $16.4B, up 21% from $13.6B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Handelsbanken Fonder deployed $574M of net new capital in Q4 2020, opening 122 new positions and adding to 458 existing holdings. Its largest new stake was Hyliion Holdings: 2,076,551 shares worth $34.2M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Daqo New Energy, an estimated $49.1M trimmed.

  • Handelsbanken Fonder's largest Q4 2020 buy was Hyliion Holdings: 2,076,551 shares worth $34.2M.
  • Handelsbanken Fonder added most to Sunrun in Q4 2020, an estimated $59.8M increase.
  • Handelsbanken Fonder's biggest Q4 2020 reduction was Daqo New Energy, cutting an estimated $49.1M.
  • Handelsbanken Fonder fully exited Momenta Pharmaceuticals, Inc. in Q4 2020, selling an estimated $14M.
  • Handelsbanken Fonder's ten largest holdings make up 21% of its $16.4B portfolio in Q4 2020.
  • Handelsbanken Fonder opened 122 new positions and closed 28 in Q4 2020.
  • Handelsbanken Fonder's portfolio value rose 21% quarter-over-quarter to $16.4B.

Based on Handelsbanken Fonder's 13F filing for Q4 2020, filed 11 Feb 2021.